The Relationship between T Lymphocyte Subsets and Pathological Characteristics of Acute Myeloid Leukemia and the Value of Predicting Chemotherapy Prognosis

Chunyan LIU; Bingqing CHANG; Chao LI; Xin REN; Xiaoqin LIU

doi:10.12259/j.issn.2095-610X.S20240518

Volume 45 Issue 5

May 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(5): 116-122

Chunyan LIU, Bingqing CHANG, Chao LI, Xin REN, Xiaoqin LIU. The Relationship between T Lymphocyte Subsets and Pathological Characteristics of Acute Myeloid Leukemia and the Value of Predicting Chemotherapy Prognosis[J]. Journal of Kunming Medical University, 2024, 45(5): 116-122. doi: 10.12259/j.issn.2095-610X.S20240518

Citation:

Chunyan LIU, Bingqing CHANG, Chao LI, Xin REN, Xiaoqin LIU. The Relationship between T Lymphocyte Subsets and Pathological Characteristics of Acute Myeloid Leukemia and the Value of Predicting Chemotherapy Prognosis[J]. Journal of Kunming Medical University, 2024, 45(5): 116-122. doi: 10.12259/j.issn.2095-610X.S20240518

Citation:

Chunyan LIU, Bingqing CHANG, Chao LI, Xin REN, Xiaoqin LIU. The Relationship between T Lymphocyte Subsets and Pathological Characteristics of Acute Myeloid Leukemia and the Value of Predicting Chemotherapy Prognosis[J]. Journal of Kunming Medical University, 2024, 45(5): 116-122. doi: 10.12259/j.issn.2095-610X.S20240518

PDF( 640 KB)

The Relationship between T Lymphocyte Subsets and Pathological Characteristics of Acute Myeloid Leukemia and the Value of Predicting Chemotherapy Prognosis

doi: 10.12259/j.issn.2095-610X.S20240518

1.
Dept.of Hematology，Beijing Aerospace General Hospital，Beijing 100076
2.
Dept. of Rheumatology and Immunology，Kaizhou District People's Hospital，Chongqing 405499，China

Received Date: 2024-01-15
Available Online: 2024-04-26
Publish Date: 2024-05-31

Abstract

Abstract

Objective To analyze the relationship between the level of peripheral blood T lymphocyte subsets and the pathological characteristics of patients with acute myeloid leukemia （AML）, as well as its prognostic value for chemotherapy. Methods A total of 80 patients with AML in Beijing Aerospace General Hospital from April 2017 to April 2022 were selected as the study group, and 80 healthy volunteers matched for gender and age were selected as the control group. The general data and peripheral blood T lymphocyte subsets levels （CD4⁺/CD8⁺, CD3⁺ and CD4⁺） of the two groups were compared, and the peripheral blood T lymphocyte subsets levels of patients with different pathological characteristics in the study group before the chemotherapy were compared.The clinical data and peripheral blood T lymphocyte subsets of patients with the different prognosis were compared in the study group, and the influencing factors of poor prognosis of AML were analyzed, and the value of peripheral blood T lymphocyte subsets in predicting poor prognosis of AML was analyzed. Results Compared with the control group, the levels of peripheral blood CD4⁺/CD8⁺, CD3⁺ and CD4⁺ in the study group before the chemotherapy were significantly decreased （P < 0.05）; the levels of CD4⁺/CD8⁺, CD3⁺ and CD4⁺ in peripheral blood of patients with positive NPM1 mutation, positive FLT3-ITD mutation, and low-risk stratification were higher than those of patients with negative NPM1 mutation, negative FLT3-ITD mutation, and high-risk stratification, respectively （P < 0.05）; The age and high-risk stratification of the poor prognosis patients in the research group were higher than those of the good prognosis patients, and the levels of CD4⁺/CD8⁺, CD3⁺ and CD4⁺ in peripheral blood before chemotherapy were lower than those of the good prognosis patients （P < 0.05）; Age, risk stratification, CD4⁺/CD8⁺, the CD3⁺ and CD4⁺ levels in peripheral blood before the chemotherapy were all factors influencing poor prognosis in AML patients （P < 0.05）; The areas under the curve （AUC） of CD4⁺/CD8⁺, CD3⁺ and CD4⁺ in peripheral blood before the chemotherapy for predicting poor prognosis in AML were 0.702, 0.738, and 0.759, respectively. Conclusion The decrease in CD4⁺/CD8⁺, CD3⁺ and CD4⁺ levels in peripheral blood of AML patients is associated with NPM1 mutation, FLT3-ITD mutation and risk stratification, and has certain predictive value in predicting poor prognosis of AML.
- Acute myeloid leukemia,
- T lymphocyte subsets,
- Prognosis,
- Forecast

FullText(HTML)

References(21)

References

[1]	Pelcovits A,Niroula R. Acute myeloid leukemia: A review[J]. R I Med J (2013),2020,103(3): 38-40.
[2]	Pabon C M,Abbas H A,Konopleva M. Acute myeloid leukemia: Therapeutic targeting of stem cells[J]. Expert Opin Ther Targets,2022,26(6):547-556. doi: 10.1080/14728222.2022.2083957
[3]	Vago L,Gojo I. Immune escape and immunotherapy of acute myeloid leukemia[J]. J Clin Invest,2020,130(4):1552-1564. doi: 10.1172/JCI129204
[4]	Lasry A,Nadorp B,Fornerod M,et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia[J]. Nat Cancer,2023,4(1):27-42.
[5]	李翠,王卫国,罗兵,等. 急性髓系细胞白血病淋巴细胞亚群与预后的关系[J]. 长春中医药大学学报,2023,39(6):678-682.
[6]	Corradi G,Bassani B,Simonetti G,et al. Release of IFNγ by acute myeloid leukemia cells remodels bone marrow immune microenvironment by inducing regulatory T cells[J]. Clin Cancer Res,2022,28(14):3141-3155. doi: 10.1158/1078-0432.CCR-21-3594
[7]	中华医学会血液学分会白血病淋巴瘤学组. 成人急性髓系白血病(非急性早幼粒细胞白血病)中国诊疗指南(2017年版)[J]. 中华血液学杂志,2017,38(3):177-182. doi: 10.3760/cma.j.issn.0253-2727.2017.03.001
[8]	Döhner H,Estey E,Grimwade D,et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel[J]. Blood,2017,129(4):424-447. doi: 10.1182/blood-2016-08-733196
[9]	Newell L F,Cook R J. Advances in acute myeloid leukemia[J]. BMJ,2021,375(1):n2026.
[10]	Shimony S,Stahl M,Stone R M. Acute myeloid leukemia: 2023 update on diagnosis,risk-stratification,and management[J]. Am J Hematol,2023,98(3):502-526. doi: 10.1002/ajh.26822
[11]	Li Z,Philip M,Ferrell P B. Alterations of T-cell-mediated immunity in acute myeloid leukemia[J]. Oncogene,2020,39(18):3611-3619. doi: 10.1038/s41388-020-1239-y
[12]	黄方,郝思国. 急性髓系白血病患者外周血T淋巴细胞亚群的水平变化及临床意义[J]. 第二军医大学学报,2020,41(5):546-550.
[13]	Pepeldjiyska E,Li L,Gao J,et al. Leukemia derived dendritic cell (DCleu) mediated immune response goes along with reduced (leukemia-specific) regulatory T-cells[J]. Immunobiology,2022,227(4):152237. doi: 10.1016/j.imbio.2022.152237
[14]	冯爱梅,赵朴,徐钰,等. 急性白血病患者免疫指标、凝血指标、基质衍生因子-1α及乳酸脱氢酶的检测及其临床意义[J]. 中国卫生检验杂志,2020,30(2):183-185.
[15]	王晓萍,李启欣,林静. 急性髓系白血病患者外周血T淋巴细胞亚群表达水平及其与临床病理特征的关系[J]. 检验医学与临床,2022,19(12):1639-1643.
[16]	陈月梅,金咏梅,曾婷婷,等. FLT3-ITD等多种基因突变原发性急性髓系白血病伴BCR-ABL1患者实验室检测结果分析[J]. 检验医学,2022,37(4):365-369.
[17]	张秋蓉,吴晓,黄琨,等. 伴有核仁磷酸蛋白1突变的老年急性髓系白血病患者的临床特征及预后因素分析[J]. 癌症进展,2020,18(2):182-185,194.
[18]	Tan J,Yu Z,Huang J,et al. Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML[J]. Biomark Res,2020,8(1):6. doi: 10.1186/s40364-020-0185-8
[19]	糜英华,高登鹏,李荣,等. 中低位进展期直肠癌患者外周血T淋巴细胞亚群水平变化对新辅助同步放化疗效果的影响[J]. 临床和实验医学杂志,2021,20(17):1850-1853.
[20]	张雨,徐丹. 急性髓系白血病患者外周血淋巴细胞亚群变化的临床意义[J]. 中国地方病防治,2022,37(2):171-173.
[21]	吴秀继,王永卿,杨晓阳,等. 急性期蛋白对急性髓系白血病患者预后的预测价值[J]. 中国实验血液学杂志,2022,30(4):1086-1093.

Relative Articles(20)

Relative Articles

[1]	Lizhu ZHAO, Ying DONG, Yue DENG, Lihua YANG. Correlation between Epithelial Cell Related Genes and Prognosis of Patients with Ovarian Cancer based on Single Cell Sequencing. Journal of Kunming Medical University, 2024, 45(4): 9-16. doi: 10.12259/j.issn.2095-610X.S20240402
[2]	Qi NIE, Li LIU, Yue TIAN, Xiaoyan MAO, Qulian GUO, Xin TIAN. Abnormal Clinical Features and Prognosis of ACTH in Pediatric Acute B Lymphocytic Leukemia. Journal of Kunming Medical University, 2024, 45(10): 75-84. doi: 10.12259/j.issn.2095-610X.S20241012
[3]	Ruiting ZHANG, Bin YAN, Zuyan LI, Jinmin SUN, Jin YAO. Relations between Peripheral Blood Blast Clearance Time and Albumin Level at Initial Diagnosis during Induction Chemotherapy and Genetic Mutations and Prognosis in Patients with Acute Myeloid Leukemia. Journal of Kunming Medical University, 2024, 45(8): 117-124. doi: 10.12259/j.issn.2095-610X.S20240817
[4]	Jiefu TANG, Dexing YANG, Shengzhe LIU, Qiang WANG, Kai FU, Zhenfang WANG, Ying LUAN, Min LI, Rong LIU. A Study on Prognostic Value of Cellular Immunological Indicators in Omicron Variant Infected Elderly Severe Patients. Journal of Kunming Medical University, 2023, 44(12): 87-94. doi: 10.12259/j.issn.2095-610X.S20231214
[5]	Hong LI. Quantitative Analysis of Real-time Ultrasound Elastography in Elderly Patients with Advanced Malignant Obstructive Jaundice and the Assessment of Prognostic Value of PTCD. Journal of Kunming Medical University, 2023, 44(1): 122-127. doi: 10.12259/j.issn.2095-610X.S20230123
[6]	Li CAI, Huaying YANG, Jianhong CHENG, Jia CAO, Na WEI. Changes of Serum Levels of 6-Keto-PGF1α，TGF-α and TXB2 during the Treatment of Peptic Ulcer in Children and Their Influence on Prognosis. Journal of Kunming Medical University, 2023, 44(9): 136-142. doi: 10.12259/j.issn.2095-610X.S20230928
[7]	Yike ZHU, Junsu YANG, Fang QIAN, Haohao WU, Baogang HUANG. Correlation between NLR Value and Prognosis in Patients with Acute Ischemic Stroke before and after Revascularization. Journal of Kunming Medical University, 2022, 43(8): 100-105. doi: 10.12259/j.issn.2095-610X.S20220815
[8]	Ruijuan MA, Feng ZHANG, Ruiting ZHANG, Jin YAO. Effect of Hematopoietic Function Recovery and MRD Status after Induction Chemotherapy on the Prognosis of Patients with Newly Diagnosed Acute Myeloid Leukemia. Journal of Kunming Medical University, 2022, 43(5): 88-94. doi: 10.12259/j.issn.2095-610X.S20220512
[9]	Zhong FANG, Xiao-dong XU, Li-hua WANG, Ying ZHANG, Chao MA. Prognostic Value of eGFR and NT-proBNP in Patients with Chronic Heart Failure Complicated with Atrial Fibrillation. Journal of Kunming Medical University, 2021, 42(11): 111-116. doi: 10.12259/j.issn.2095-610X.S20211120
[10]	Shan HUANG, Song-qin LV, Hong-fen DUAN, Jin-li SHI, Guang-min LI, Gang HUANG, Jia-neng LI, Xiao-fei LI. Cohort Study on the Influence of Opportunistic Infectious Pathogens on the Distribution of Peripheral Blood T Lymphocyte Subsets in Newly Acquired AIDS Patients During Antiretroviral Therapy. Journal of Kunming Medical University, 2021, 42(11): 159-165. doi: 10.12259/j.issn.2095-610X.S20211128
[11]	Zhe GE, Si-ping LU, Shi-zhong FU, Chun-hong WANG, Shao-ying LI, Ao LIU. The Preliminary Application of Whole Blood Interferon-Gamma Release Assay Combined with T Lymphocyte Subset Detection in Diagnosis of Pulmonary Tuberculosis. Journal of Kunming Medical University, 2021, 42(9): 108-113. doi: 10.12259/j.issn.2095-610X.S20210901
[12]	Qi Fei , Xia Jia Wei , Zhang Le , Liu Li , Yang Ya Tao , Tang Li Bin , Liu Hui , Shen Han Zhang . . Journal of Kunming Medical University, 2020, 41(04): 56-59.
[13]	Lv Song Qin , Huang Shan , Li Xiao Fei , Shi Jin Li , Li Guang Min , Duan Hong Fen . Application of T-lymphocyte Subsets for Non-viral Liver Disease. Journal of Kunming Medical University, 2019, 40(03): 107-111.
[14]	Wu Wen Juan . Combination of Heart-type Fatty Acid-binding Protein and Simple Pulmonary Embolism Severity Index for the Assessment of the Short-term Prognosis in Patients with Acute Pulmonary Embolism. Journal of Kunming Medical University,
[15]	Liu Ning . The Clinical Value of T Lymphocyte Subsets Analysis with Flow Cytometry in Bronchoalveolar Lavage Fluid of Patients with Pulmonary Tuberculosis. Journal of Kunming Medical University,
[16]	Yang Hong . . Journal of Kunming Medical University,
[17]	Lu Ni Hong . . Journal of Kunming Medical University,
[18]	Pang Ming Jie . . Journal of Kunming Medical University,
[19]	Tan Xiang Lai . . Journal of Kunming Medical University,
[20]	Hu Wan Qin . . Journal of Kunming Medical University,